1Le CF, Funck BC, Morell T, et al. Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization. [J]. Clin Pharmacol Ther,1995,57(5) :533.
2Walker DK, Alabaster CT, Congrave GS, et al. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data [J]. Drug Metab Dispos, 1996,24(4) :447.
3Allen MJ, Nichols DJ, Oliver SD. The pharmacokinetics and pharmacodynamics of oral dofetilide after twice daily and three times daily dosing[J]. Br J Clin Pharmacol, 2000 , 50(3) : 247 .
4AbelS, Nichols DJ, Brearley CJ, et al. Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide[J]. Br J Clin Pharmacol,2000,49(1):64.
5Chojnowska-Jezierska J. Undesirable drug interactions of hypolipemic drugs[J]. Pol Merkuriusz Lek ,2000,9:618.
6Singh S,Zoble RG, Yellen L, et al.Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide
7McClellan KJ, Markham A. Dofetilide: a review of its use in atrial fibrillation and atrial flutter[J]. Drugs, 1999,58(Suppl 6):S1043.
8Lindeboom JE, Kingma JH, Crijns HJ, et al. Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter[J]. Am J Cardiol,2000,85(Suppl 8) :S1031.
9Boriani G, Lubinski A, Capucci A, et al. A multicentre, doubleblind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease[J]. Eur
10Pool PE, Singh SN, Friedrich T, et al. Effects of intravenous dofetilide in patients with frequent premature ventricular contractions: a clinical trial[J]. Clin Cardiol,2000,23(Suppl 6):S415.
